Related Experiment Video
Updated: Jan 8, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Should Slowing Senescence Be Regarded as a Legitimate Enterprise of Health Care?
1Professor of medicine at the University of Washington School of Medicine in Seattle.
Abstract:
Dementia is one of the most common developments in our increasing human lifespan. Preventing and postponing it have been important projects of health care that rely on the approval and use of interventions, sometimes in the absence of clinical or ethical consensus about what constitutes meaningful clinical improvement, outcomes, or risk factor modification. This commentary on a case considers these variables and proposes how to improve the general health and well-being of older persons.
Related Concept Videos
Replicative Cell Senescence
The Effect of Aging on Tissues
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Whole Body Regeneration
Pharmacodynamics in Geriatric Patients: Effects of Age
Tissue Renewal without Stem Cells
However, failure of such a system...

